Article Information
History
- May 12, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 12, 2020 - 14:44).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Liqun He1,*,
- Maarja Andaloussi Mäe1,*,
- Ying Sun1,
- Lars Muhl2,
- Khayrun Nahar1,
- Elisa Vázquez Liébanas1,
- Malin Jonsson Fagerlund3,
- Anders Oldner3,
- Jianping Liu2,
- Guillem Genové2,
- Riikka Pietilä1,
- Lei Zhang4,
- Yuan Xie4,
- Stefanos Leptidis2,
- Guiseppe Mocci2,
- Simon Stritt1,
- Ahmed Osman5,
- Andrey Anisimov6,
- Karthik Amudhala Hemanthakumar6,
- Markus Räsenen6,
- Johan Björkegren2,7,8,9,
- Michael Vanlandewijck2,
- Klas Blomgren5,10,
- Emil Hansson2,
- Taija Mäkinen1,
- Xiao-Rong Peng11,
- Thomas D. Arnold12,
- Kari Alitalo6,
- Lars I Eriksson3,
- Urban Lendahl2,13 and
- Christer Betsholtz1,2,14,§
- 1Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
- 2Integrated Cardio Metabolic Center (ICMC), Karolinska Institutet, Huddinge, Sweden
- 3Department of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care Medicine, Karolinska Institutet, Solna and Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden
- 4Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi’an, China
- 5Department of Women’s and Children’s Health, Karolinska Institutet, Solna, Sweden
- 6Wihuri Research Institute and Translational Cancer Medicine Program, Biomedicum Helsinki, University of Helsinki, Finland
- 7Institute of Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, US
- 8Department of Pathophysiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
- 9Clinical Gene Networks AB, Stockholm, Sweden
- 10Cardiovascular, Renal and Metabolism (CVRM), IMED Biotech Unit, AstraZeneca BioPharmaceuticals R&D, Gothenburg, Sweden
- 11Department of Pediatric oncology, Karolinska University Hospital, Stockholm, Sweden
- 12Department of Pediatrics, University of California San Francisco, USA
- 13Department of Cell and Molecular Biology, Karolinska Institutet, Sweden
- 14Department of Medicine Huddinge, Karolinska Institutet, Sweden
- ↵§Correspondence: christer.betsholtz{at}ki.se or christer.betsholtz{at}igp.uu.se
↵* Shared contribution
Posted May 12, 2020.
Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 – implications for microvascular inflammation and hypercoagulopathy in COVID-19 patients
